Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE24-011, Grants To Support New Investigators in Conducting Research Related To Understanding Drug Use and Overdose Risk and Protective Factors (K01); Cancellation of Meeting, 7717 [2024-02208]
Download as PDF
<![CDATA[
7717
Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Cities
Cities
Cities
Cities
Cities
.............................................
.............................................
.............................................
.............................................
.............................................
Weekly (Automated) .........................................................
Weekly (Non-automated) ..................................................
Weekly (DMI Implementation) ..........................................
Annual ...............................................................................
One-time Addition of Diseases and Data Elements ........
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–02171 Filed 2–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—CE24–011,
Grants To Support New Investigators
in Conducting Research Related To
Understanding Drug Use and
Overdose Risk and Protective Factors
(K01); Cancellation of Meeting
Centers for Disease Control and
Prevention, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
FOR FURTHER INFORMATION CONTACT:
Aisha L. Wilkes, M.P.H., Scientific
Review Officer, National Center for
Injury Prevention and Control, Centers
for Disease Control and Prevention,
4770 Buford Highway NE, Mailstop
S106–9, Atlanta, Georgia 30341–3717.
Telephone: (404) 639–6473; Email:
AWilkes@cdc.gov.
Notice is
hereby given of a change in the meeting
of the Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—CE24–011,
Grants to Support New Investigators in
Conducting Research Related to
Understanding Drug Use and Overdose
Risk and Protective Factors (K01);
Cancellation of Meeting; March 5, 2024,
8:30 a.m.–5 p.m., EST., in the original
Federal Register notice FRN. The web
conference was published in the
Federal Register on Tuesday, October
24, 2023, 88 FR 73020.
This meeting is being canceled in its
entirety.
lotter on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:56 Feb 02, 2024
Jkt 262001
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02208 Filed 2–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-24–0696; Docket No. CDC–2024–
0006]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National HIV
Prevention Program Monitoring and
Evaluation (NHM&E). NHM&E collects
standardized HIV prevention program
evaluation data from health departments
and community-based organizations
(CBOs) who receive federal funds for
HIV prevention activities.
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Number of
responses per
respondent
Number of
respondents
Form name
Sfmt 4703
2
2
2
2
2
52
52
52
1
1
Average
burden per
response
(in hours)
20/60
2
4
75
3
CDC must receive written
comments on or before April 5, 2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0006 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
DATES:
E:\FR\FM\05FEN1.SGM
05FEN1
]]>Agencies
[Federal Register Volume 89, Number 24 (Monday, February 5, 2024)]
[Notices]
[Page 7717]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02208]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--CE24-011, Grants To Support New Investigators in
Conducting Research Related To Understanding Drug Use and Overdose Risk
and Protective Factors (K01); Cancellation of Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific
Review Officer, National Center for Injury Prevention and Control,
Centers for Disease Control and Prevention, 4770 Buford Highway NE,
Mailstop S106-9, Atlanta, Georgia 30341-3717. Telephone: (404) 639-
6473; Email: [email protected].
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the
meeting of the Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP)--CE24-011, Grants to Support New
Investigators in Conducting Research Related to Understanding Drug Use
and Overdose Risk and Protective Factors (K01); Cancellation of
Meeting; March 5, 2024, 8:30 a.m.-5 p.m., EST., in the original Federal
Register notice FRN. The web conference was published in the Federal
Register on Tuesday, October 24, 2023, 88 FR 73020.
This meeting is being canceled in its entirety.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02208 Filed 2-2-24; 8:45 am]
BILLING CODE 4163-18-P
